CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Government regulations

3.3.1 U.S. FDA
3.3.2 Europe CE mark
3.3.3 Others

3.4 Reimbursement scenarios
3.5 Clinical trials
3.6 Patent analysis

3.6.1 Patent analysis, by year
3.6.2 Patent analysis, by company

3.7 Top impacting factors

3.7.1 Drivers

3.7.1.1 Rise in the prevalence of chronic illnesses
3.7.1.2 Technological advancements
3.7.1.3 Short duration and high efficacy of the procedure

3.7.2 Restraints

3.7.2.1 Government regulations and reimbursement policies
3.7.2.2 High cost and limited awareness

3.7.3 Opportunities

3.7.3.1 Increase in the level of awareness
3.7.3.2 Untapped markets in emerging economies

CHAPTER 4 WORLD ABLATION DEVICES MARKET, BY TECHNOLOGY

4.1 Overview

4.1.1 Market size and forecast

4.2 Thermal ablation technology

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Radiofrequency ablation

4.2.4.1 Market size and forecast
4.2.4.2 Temperature-controlled radiofrequency ablation devices
4.2.4.3 Market size and forecast
4.2.4.4 Fluid-cooled radiofrequency ablation
4.2.4.5 Market size and forecast
4.2.4.6 Catheter manipulation system
4.2.4.7 Market size and forecast

4.2.5 Electrical ablation

4.2.5.1 Market size and forecast
4.2.5.2 Electrical ablators
4.2.5.3 Market size and forecast
4.2.5.4 Argon plasma/beam coagulator
4.2.5.5 Market size and forecast
4.2.5.6 Irreversible electroporation
4.2.5.7 Market size and forecast
4.2.5.8 Electronic brachytherapy
4.2.5.9 Market size and forecast

4.2.6 Microwave

4.2.6.1 Market size and forecast

4.2.7 Hydrothermal ablation

4.2.7.1 Market size and forecast

4.2.8 Light ablation

4.2.8.1 Market size and forecast
4.2.8.2 Cold laser
4.2.8.3 Market size and forecast
4.2.8.4 Excimer laser
4.2.8.5 Market size and forecast

4.2.9 Radiation ablation

4.2.9.1 Market size and forecast
4.2.9.2 Brachytherapy
4.2.9.3 Market size and forecast
4.2.9.4 High-dose-rate brachytherapy
4.2.9.5 Market size and forecast
4.2.9.6 Pulsed-dose-rate brachytherapy
4.2.9.7 Market size and forecast
4.2.9.8 Permanent seed brachytherapy or low-dose-rate brachytherapy
4.2.9.9 Market size and forecast
4.2.9.10 Stereotactic radiotherapy and radiosurgery
4.2.9.11 Market size and forecast
4.2.9.12 Image-guided radiation therapy
4.2.9.13 Market size and forecast
4.2.9.14 Intensity-modulated radiation therapy
4.2.9.15 Market size and forecast
4.2.9.16 Stereotactic body radiation therapy
4.2.9.17 Market size and forecast
4.2.9.18 Proton beam therapy
4.2.9.19 Market size and forecast

4.2.10 Ultrasound ablation

4.2.10.1 Market size and forecast
4.2.10.2 High-intensity focused ultrasound
4.2.10.3 Market size and forecast
4.2.10.4 Magnetic resonance imaging guided focus ultrasound (MRI-FUS)
4.2.10.5 Market size and forecast
4.2.10.6 Ultrasonic surgical systems
4.2.10.7 Market size and forecast
4.2.10.8 Shock wave lithotripsy
4.2.10.9 Market size and forecast

4.3 Non-thermal ablation technology

4.3.1 Key market trends
4.3.2 Key growth opportunities and opportunities
4.3.3 Market size and forecast
4.3.4 Cryoablation

4.3.4.1 Market size and forecast
4.3.4.2 Tissue contact probe
4.3.4.3 Market size and forecast
4.3.4.4 Cryogen spray probe
4.3.4.5 Market size and forecast
4.3.4.6 Epidermal and subcutaneous cryoablation devices
4.3.4.7 Market size and forecast

4.3.5 Hydromechanical

4.3.5.1 Market size and forecast

CHAPTER 5 WORLD ABLATION DEVICES MARKET, BY APPLICATION

5.1 Overview

5.1.1 Market size and forecast

5.2 Cancer

5.2.1 Market size and forecast

5.3 Cardiovascular

5.3.1 Market size and forecast

5.4 Ophthalmology

5.4.1 Market size and forecast

5.5 Gynecology

5.5.1 Market size and forecast

5.6 Urology

5.6.1 Market size and forecast

5.7 Orthopedics

5.7.1 Market size and forecast

5.8 Others

5.8.1 Market size and forecast

CHAPTER 6 WORLD ABLATION DEVICES MARKET, BY FUNCTION

6.1 Overview

6.1.1 Market size and forecast

6.2 Automated/robotic ablation devices

6.2.1 Market size and forecast

6.3 Conventional ablation devices

6.3.1 Market size and forecast

CHAPTER 7 WORLD ABLATION DEVICES MARKET, BY PROCEDURE

7.1 Overview

7.1.1 Market size and forecast

7.2 Aesthetics-skin rejuvenation and tightening

7.2.1 Market size and forecast

7.3 Aesthetics-body sculpting, fat reduction, and the minimization in the appearance of cellulite

7.3.1 Market size and forecast

7.4 Benign prostatic hyperplasia

7.4.1 Market size and forecast

7.5 Transurethral needle ablation

7.5.1 Market size and forecast

7.6 Laser and other energy-based therapies/holmium laser ablation /enucleation of the prostate

7.6.1 Market size and forecast

7.7 Stress urinary incontinence

7.7.1 Market size and forecast

7.8 Menorrhagia/endometrial ablation

7.8.1 Market size and forecast

7.9 Uterine fibroids

7.9.1 Market size and forecast

7.10 Spinal decompression and denervation

7.10.1 Market size and forecast

7.11 Varicose veins

7.11.1 Market size and forecast

7.12 Atrial fibrillation

7.12.1 Market size and forecast

7.13 Tumor ablation

7.13.1 Market size and forecast

7.14 Others

7.14.1 Market size and forecast

CHAPTER 8 WORLD ABLATION DEVICES MARKET, BY GEOGRAPHY

8.1 Overview

8.1.1 Market size and forecast

8.2 North America

8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.2.4 U.S. market size and forecast
8.2.5 Canada market size and forecast
8.2.6 Mexico market size and forecast

8.3 Europe

8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.3.4 Germany market size and forecast
8.3.5 France market size and forecast
8.3.6 UK market size and forecast
8.3.7 Italy market size and forecast
8.3.8 Spain market size and forecast
8.3.9 Russia market size and forecast
8.3.10 Rest of Europe market size and forecast

8.4 Asia-Pacific

8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.4.4 Japan market size and forecast
8.4.5 China market size and forecast
8.4.6 Australia market size and forecast
8.4.7 India market size and forecast
8.4.8 South Korea market size and forecast
8.4.9 Taiwan market size and forecast
8.4.10 Rest of Asia-Pacific market size and forecast

8.5 Latin America, Middle East, And Africa (LAMEA)

8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast
8.5.4 Brazil market size and forecast
8.5.5 Turkey market size and forecast
8.5.6 Venezuela market size and forecast
8.5.7 Saudi Arabia market size and forecast
8.5.8 Republic of South Africa market size and forecast
8.5.9 Rest of LAMEA market size and forecast

CHAPTER 9 COMPANY PROFILES

9.1 Medtronic PLC

9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Business performance
9.1.5 Key strategic moves and developments

9.2 Johnson and Johnson

9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Business performance
9.2.5 Key strategic moves and developments

9.3 St. Jude Medical, Inc.

9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Business performance
9.3.5 Key strategic moves and developments

9.4 Boston Scientific Corporation

9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Business performance
9.4.5 Key strategic moves and developments

9.5 AngioDynamics, Inc.

9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Business performance
9.5.5 Key strategic moves and developments

9.6 AtriCure, Inc.

9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Business performance
9.6.5 Key strategic moves and developments

9.7 Conmed Corporation

9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Business performance
9.7.5 Key strategic moves and developments

9.8 Olympus Corporation

9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Business performance
9.8.5 Key strategic moves and developments

9.9 Smith & Nephew PLC

9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Business performance
9.9.5 Key strategic moves and developments

9.10 BTG plc

9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Business performance
9.10.5 Key strategic moves and developments

Other players in the RPM market include (profiles not included in the report)

Accuray Incorporated
C.R. Bard, Inc.
Varian Medical Systems, Inc.
Elekta AB
Misonix, Inc.
Hologic, Inc.
Stryker Corporation
EDAP TMS S.A.
Japan Lifeline Co., Ltd.
Halyard Health, Inc.
Merit Medical Systems, Inc.
Integra Lifesciences Holdings Corporation
Abbott Laboratories
Terumo Corporation